Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
MariMed Inc.
- Market Cap
- Unavailable
- Price
- $0.07
- % Change (Daily % change from the live per-ticker quote feed.)
- +2.94%
- Volume
- 364.5K
About
MariMed Inc. operates in the cannabis industry, specializing in the cultivation, production, and sale of both medicinal and adult-use cannabis items throughout the United States and internationally. The company's diverse product portfolio includes cannabis flowers and concentrates marketed under the Nature's Heritage brand. It also offers infused goods such as chewable tablets and powdered drink mixes under the Kalm Fusion label, natural fruit chews known as Betty's Eddies, and a line of baked treats like brownies and cookies available through Bubby's Baked. Furthermore, MariMed develops cannabidiol (CBD) products under the Florance brand. Beyond its own offerings, the company licenses its various brands and product formulations to others and leases facilities designed for cannabis operations. MariMed Inc., founded in 2011, is based in Norwood, Massachusetts.
Quick stats
Shares outstanding—
Computed float332.0M
Float / sharesUnknown
Key info
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001522767
Websitehttps://www.marimedinc.com
AI Summary
AI-generated1/12
standardmixedearnings
MariMed Reports Second Quarter 2026 Earnings
MariMed reported record second-quarter revenue of $41.9 million, up 6% year-over-year, driven by sequential growth in wholesale and retail segments.
However, profitability weakened as the GAAP net loss widened to $3.6 million from $1.4 million in the prior year, and adjusted EBITDA margin contracted to 9.4%.
Management noted positive operating cash flow and highlighted brand strength, with Betty's Eddies remaining the top-selling edible brand across its core markets.
Red flags
- Net loss widened to $3.6 million from $1.4 million year-over-year
- Adjusted EBITDA margin contracted to 9.4% from 12.1% year-over-year